Acutaas Chemicals Limited vs Onesource Specialty Pharma Limited
An objective side-by-side of ACUTAAS and ONESOURCE, both in Pharmaceuticals: valuation, profitability, growth, balance sheet, ownership and share-price performance. Where one number is clearly better on its own terms (lower P/E, higher ROE), it is shaded. That is a description, not a recommendation.
Prices as of 2026-11-06 close
Latest results: ACUTAAS Sep 2026 · ONESOURCE Sep 2026
At a glance
- Acutaas Chemicals Limited is the larger company by market value, about 1.7 times the size of Onesource Specialty Pharma Limited.
- Acutaas Chemicals Limited earns the higher return on equity (23.6% against -0.0%).
- Over the past year the share prices returned +119.2% (ACUTAAS) and -13.7% (ONESOURCE).
| Metric | Acutaas Chemicals ACUTAAS |
Onesource Specialty ONESOURCE |
|---|---|---|
| Size and price | ||
| Market cap | ₹31,001 Cr | ₹18,346 Cr |
| Share price | ₹3,786.60 | ₹1,599.80 |
| Valuation | ||
| P/E | 70.76 | — |
| P/B | 16.69 | 3.10 |
| EV/EBITDA | 49.70 | 50.82 |
| Dividend yield | — | 0.0% |
| Profitability | ||
| ROE | 23.6% | -0.0% |
| ROCE | — | 1.0% |
| Operating margin | 39.2% | 23.5% |
| Sales (TTM) | ₹1,593 Cr | ₹1,684 Cr |
| Net profit (TTM) | ₹438 Cr | ₹-2 Cr |
| Growth | ||
| Latest quarter sales YoY | +42.7% | +37.3% |
| Latest quarter profit YoY | +71.4% | +474.8% |
| Sales CAGR 3Y | — | +232.0% |
| Profit CAGR 3Y | — | +24.0% |
| Sales CAGR 5Y | — | +131.0% |
| Profit CAGR 5Y | — | +8.0% |
| Financial strength | ||
| Debt/Equity | 0.01 | 0.30 |
| Interest cover | 138.23 | 0.19 |
| Ownership | ||
| Promoter holding | 32.7% | 30.5% |
| Promoter change (4 qtrs) | — | +0.70 pp |
| Price performance | ||
| Return 1M | +19.29% | +4.66% |
| Return 3M | +16.13% | +2.74% |
| Return 1Y | +119.17% | -13.72% |
| Return YTD | +122.10% | -11.64% |
| Technical condition | ||
| Technical score | 77 | 70 |
| RS rating (1-99) | 95.00 | 68.00 |
| % vs 200-DMA | +31.87% | +3.18% |
| RSI (14) | 61.66 | 61.99 |
| % from 52-week high | -6.40% | -16.89% |
